3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2C adrenoreceptor agonists

Details for Australian Patent Application No. 2008216804 (hide)

International Classifications

Event Publications

3 September 2009 PCT application entered the National Phase

PCT publication WO2008/100463 Priority application(s): WO2008/100463

10 September 2009 Assignment before Grant

SCHERING CORPORATION; PHARMACOPEIA, INC. The application has been assigned to Pharmacopeia, LLC

1 October 2009 Corrigenda

Assignments Before Grant, Section 113 - 2008 Under the name Pharmacopeia, LLC, Application No. 2008216804, under INID (71) add co-applicant SCHERING CORPORATION

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.